Improve PAD PERformance With METformin
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 202 participants.
Also called NCT03054519
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 202 participants
- Sponsor
- Registry
-
NCT03054519
-
- Main results
- Metformin to Improve Walking Performance in Lower Extremity Peripheral Artery Disease: The PERMET Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT03054519. Randomized; quadruple masking; primary purpose treatment. Start 2017-05-23 (actual); primary completion 2025-08-20 (actual). Results posted on 2026-08-24.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Improve PAD PERformance With METformin
- Acronym
- PERMET
- Condition
- Peripheral Artery Disease
- Intervention (Drug)
- Metformin
- Intervention (Drug)
- Placebo
- Lead sponsor
- Northwestern University
Record details
- Record id
cardio:ct-nct03054519- Content hash
dd30c8252b780b72383efb93a35ecadc9c3229755fe645b5cf9c034a855bfb46